One of the key messages from the EyeForPharma Multichannel Marketing Summit in London yesterday was that pharma has to look outside the industry itself and down the supply chain to prescribing clinicians and patients in order to have truly meaningful and effective marketing strategies, across multiple channels.
One of the most revealing sessions was one in which general practitioners from the UK discussed strategies that work on them, and those that don’t, and what position pharma sales reps occupy in their decision-making process as prescribers.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze